MA52337A - Nouveaux analogues d'oxaborole et utilisations de ces derniers - Google Patents

Nouveaux analogues d'oxaborole et utilisations de ces derniers

Info

Publication number
MA52337A
MA52337A MA052337A MA52337A MA52337A MA 52337 A MA52337 A MA 52337A MA 052337 A MA052337 A MA 052337A MA 52337 A MA52337 A MA 52337A MA 52337 A MA52337 A MA 52337A
Authority
MA
Morocco
Prior art keywords
oxaborole
analogues
latest
new
oxaborole analogues
Prior art date
Application number
MA052337A
Other languages
English (en)
Inventor
Paul Alan Glossop
Robert Toms Jacobs
Delphine Françoise Monique Launay
Yang Liu
Charles Eric Mowbray
Stephen John Robinson
Richard J Sciotti
Jason D Speake
Gavin Alistair Whitlock
Original Assignee
Anacor Pharmaceuticals Inc
Us Gov Sec Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc, Us Gov Sec Army filed Critical Anacor Pharmaceuticals Inc
Publication of MA52337A publication Critical patent/MA52337A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA052337A 2017-03-01 2018-03-01 Nouveaux analogues d'oxaborole et utilisations de ces derniers MA52337A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762465294P 2017-03-01 2017-03-01

Publications (1)

Publication Number Publication Date
MA52337A true MA52337A (fr) 2021-03-03

Family

ID=63370509

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052337A MA52337A (fr) 2017-03-01 2018-03-01 Nouveaux analogues d'oxaborole et utilisations de ces derniers

Country Status (4)

Country Link
US (2) US10961261B2 (fr)
EP (1) EP3609504A4 (fr)
MA (1) MA52337A (fr)
WO (1) WO2018160845A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
RS64770B1 (sr) 2016-03-07 2023-11-30 Agrofresh Inc Sinergistički postupci upotrebe jedinjenja benzoksaborola i gasova za prezerviranje kao antimikrobnih agenasa za useve
MA52337A (fr) 2017-03-01 2021-03-03 Anacor Pharmaceuticals Inc Nouveaux analogues d'oxaborole et utilisations de ces derniers
EP4204012A1 (fr) 2020-08-31 2023-07-05 Pfizer Inc. Procédés de protection de l'arn
CN118891254A (zh) 2022-04-28 2024-11-01 日本农药株式会社 具有肟基的含氮杂环化合物、及含有该化合物的农业园艺用除草剂以及其使用方法
TR2023001878A1 (tr) * 2023-02-20 2024-08-21 Univ Yeditepe Borun nöronal kaynakli lei̇shmani̇asi̇s hastaliğinin tedavi̇si̇ i̇çi̇n kullanimi
CN118724752B (zh) * 2023-03-29 2025-11-28 重庆博腾制药科技股份有限公司 一种酪氨酸激酶抑制剂中间体、制备方法及其应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1980564A1 (fr) 2002-12-18 2008-10-15 Anacor Pharmaceuticals, Inc. Antibiotiques contenant des complexes d'acide boronique et procédés d'utilisation
BRPI0411582A (pt) 2003-06-16 2006-08-08 Anacor Pharmaceuticals Inc substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso
AR049915A1 (es) 2004-06-14 2006-09-13 Anacor Pharmaceuticals Inc Compuestos con contenido de boro y metodos de uso de los mismos
PT1765360E (pt) 2004-06-14 2009-12-24 Anacor Pharmaceuticals Inc Utilizações antivirais de complexos de ácido borínico
PT1988779E (pt) 2006-02-16 2015-09-04 Anacor Pharmaceuticals Inc Moléculas pequenas contendo boro como agentes antiinflamatórios
EP2015757A4 (fr) 2006-05-02 2011-01-26 Anacor Pharmaceuticals Inc Substances thérapeutiques contenant du bore résistant à l'hydrolyse et méthodes d'utilisation
RU2008152367A (ru) 2006-06-12 2010-07-20 Анакор Фармасьютикалз, Инк. (Us) Соединения для лечения периодонтального заболевания
JO3396B1 (ar) 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
WO2009111676A2 (fr) 2008-03-06 2009-09-11 Anacor Pharmaceuticals, Inc Petites molécules contenant du bore utilisées en tant qu'agents anti-inflammatoires
US20110065725A1 (en) * 2008-03-18 2011-03-17 Glaxo Group Limited Triazole amide derivatives for use in therapy
EP2285384A4 (fr) 2008-05-12 2012-04-25 Anacor Pharmaceuticals Inc Petites molécules contenant du bore
EP2348863A4 (fr) 2008-09-04 2012-03-07 Anacor Pharmaceuticals Inc Petites molécules contenant du bore
WO2010045503A1 (fr) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore en tant qu’agents antiprotozoaires
WO2010045505A1 (fr) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc Petites molécules contenant du bore en tant qu’agents antiprotozoaires
WO2010080558A1 (fr) 2008-12-17 2010-07-15 Anacor Pharmaceuticals, Inc. Formes polymorphiques du (s)-3-aminométhyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2]oxaborol-1-ol
MX2012001156A (es) 2009-07-28 2012-05-08 Anacor Pharmaceuticals Inc Moleculas que contienen boro trisustituidas.
AP4039A (en) 2009-08-14 2017-02-28 Daitao Chen Boron-containing small molecules as antiprotozoal agents
WO2011022337A1 (fr) 2009-08-19 2011-02-24 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore en tant qu'agents anti-protozoaires
US20110124597A1 (en) 2009-09-25 2011-05-26 Anacor Pharmaceuticals, Inc. Boron containing small molecules
WO2011049971A1 (fr) 2009-10-20 2011-04-28 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore comme agents antiprotozoaires
WO2011060196A1 (fr) 2009-11-11 2011-05-19 Anacor Pharmaceuticals, Inc. Petites molecules contenant du bore
WO2011094450A1 (fr) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Petites molecules contenant du bore
AP2012006482A0 (en) 2010-03-19 2012-10-31 Anacor Pharmacueticals Inc Boron-containing small molecules as anti-protozoalagent
SI3251678T1 (sl) 2010-09-07 2022-01-31 Anacor Pharmaceuticals, Inc. Derivati benzoksaborola za zdravljenje bakterijskih okužb
WO2012145734A1 (fr) * 2011-04-22 2012-10-26 The Ohio State University Compositions antileshmaniennes et ses méthodes d'utilisation
AR088669A1 (es) 2011-11-21 2014-06-25 Lilly Co Eli Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos
AR088668A1 (es) 2011-11-21 2014-06-25 Lilly Co Eli Moleculas pequeñas que contienen boro
LT2925757T (lt) * 2012-11-19 2017-12-27 Novartis Ag Junginiai ir kompozicijos, skirti parazitinių ligų gydymui
US9598443B2 (en) * 2013-02-01 2017-03-21 Anacor Pharmaceuticals, Inc. Boron containing small molecules as antiprotozoal agents
US9493490B1 (en) 2013-07-22 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
MA52337A (fr) 2017-03-01 2021-03-03 Anacor Pharmaceuticals Inc Nouveaux analogues d'oxaborole et utilisations de ces derniers

Also Published As

Publication number Publication date
WO2018160845A1 (fr) 2018-09-07
US10961261B2 (en) 2021-03-30
US11691992B2 (en) 2023-07-04
US20200024289A1 (en) 2020-01-23
US20210253605A1 (en) 2021-08-19
EP3609504A1 (fr) 2020-02-19
EP3609504A4 (fr) 2021-03-03

Similar Documents

Publication Publication Date Title
EP3615574A4 (fr) Constructions reconnaissant spécifiquement le glypicane 3 et utilisations de ces dernieres
EP3625358A4 (fr) Biomarqueurs et utilisations de ces derniers
MA52337A (fr) Nouveaux analogues d'oxaborole et utilisations de ces derniers
EP3684366A4 (fr) Ligands crbn et utilisations de ces derniers
MA46180A (fr) Analogues de l'amyline
MA51288A (fr) Analogues d'incrétine et leurs utilisations
MA51287A (fr) Analogues d'incrétine et leurs utilisations
EP3661918A4 (fr) Analogues de 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one
MA46589A (fr) Composés et utilisations de ces derniers
EP3595694A4 (fr) Construction de furtif immunitaire cas9 crispr
EP3607587A4 (fr) Panneau d'affichage
EP3689215A4 (fr) Détermination d'attribut de région
EP3615019A4 (fr) Modulateurs de l'interaction sestrine-gator2 et utilisations de ces derniers
EP3411411A4 (fr) Composés benzopyrazole et analogues de ceux-ci
EP3580241A4 (fr) Anticorps anti-facteur d et utilisations de ces derniers
MA49847A (fr) Production enzymatique d'hexoses
EP3368663A4 (fr) Lignées cellulaires exemptes de virus et procédés d'obtention de celles-ci
EP3607053A4 (fr) Lymphocytes t spécifiques d'antigènes et utilisations de ces derniers
MA47494A (fr) Nouvelles utilisations d'anticorps anti-sirpg
EP3658560A4 (fr) Modulateurs de la somatostatine et utilisations de ces derniers
EP3347334A4 (fr) Déshydrohalogénation d'hydrochlorofluorocarbones
EP3506254A4 (fr) Structure d'insonorisation
EP3436434A4 (fr) Analogues d'indoline et leurs utilisations
EP3303366A4 (fr) Dérivés de dolastatine 10 et utilisations de ceux-ci
EP3710462A4 (fr) Analogues de brartémicine